In H2052 cells, palbociclib inhibited also HIF-1α expression and prevented its accumulation under hypoxia, confirming previous findings showing that palbociclib destabilizes HIF-1α in colon cancer cells [30]. This evidence concerns the gene HIF1A and colonic neoplasm.